Articles tagged with Neurodegenerative Diseases
Scientists have developed a technique to detect RNA structures in live cells, shedding light on the role of G-quadruplexes in neurodegenerative diseases. The method uses fluorescent spectroscopy and resolves existing limitations in studying these structures in real-time.
A University of Alberta researcher has found that fractalkine triggers the repair of brain damage caused by multiple sclerosis, leading to increased production of vital brain cells. This discovery could potentially halt or reverse MS symptoms by replacing damaged cells with new ones.
A new study finds that obesity-related neurodegeneration mimics Alzheimer's disease, with grey matter atrophy patterns similar in both groups. The researchers suggest that controlling excess weight could lead to improved health outcomes and slowed cognitive decline.
A new study found that online forums provide a sense of community and hope for people with dementia, filling an important gap in their support after diagnosis. The forums allow users to share experiences and receive emotional support from others going through similar experiences, helping to alleviate feelings of isolation.
Researchers from the University of Tsukuba have found distinct changes in brain activity patterns that can differentiate between Alzheimer's disease and Lewy body dementia. These changes were present before symptoms emerged and could be detected using conventional MRI.
The Cognitive Neuroscience Society Conference in San Francisco will explore the nature of thinking and memory. Highlights include presentations on aging, neurotechnology, and learning.
Researchers from UNIGE observed that negative emotions modify the brains of older adults excessively and over time, particularly in the posterior cingulate cortex and amygdala. This could be prevented with better emotional management, such as meditation, which could limit neurodegeneration.
A new study has identified distinct patterns of circular RNA expression in human ALS muscle tissue, which display disease-specific gradients and could inform about neuromuscular molecular programs in ALS. The research reveals that specific circRNAs are elevated in ALS muscle biopsies but reduced in spinal cord samples from ALS patients.
Researchers have discovered a possible cause of neurodegeneration in the early stages of Alzheimer's disease using fruit flies. The study found that an overabundance of the TOMM40 gene causes marked cell death in the retina, which corresponds to the level of protein produced by the gene.
A team from Brigham and Women's Hospital developed FIND-seq, a method that isolates and analyzes rare astrocytes driving MS inflammation and neurodegeneration. This approach identified signaling pathways controlling the development of pathogenic astrocytes in mice and humans.
Researchers examined associations between APOE ε2 and ε4 alleles, polygenic profiles, and Alzheimer's disease biomarkers. They found links between ε4 alleles with plasma and CSF Aβ42 and CSF tau, as well as differences in associations with tau and Aβ42.
MIT scientists use single-cell profiling to analyze the cellular function of brain cells affected by Alzheimer's disease, identifying five main areas of disruption. The study reveals specific molecular programs and gene regulation changes that could lead to valuable biomarkers and therapeutic interventions.
A recent study has identified common and unique cellular processes in six neurodegenerative diseases, providing new insights into the underlying causes of these conditions. The research used machine learning analysis to compare RNA markers in whole blood samples from patients with distinct diseases, revealing eight shared themes across...
Scientists at the CRCHUM have identified a protective probiotic for ALS, Lacticaseibacillus rhamnosus HA-114, that prevents neurodegeneration in the C. elegans worm model. The probiotic helps reduce motor disorders and restore balance to impaired energy metabolism, leading to a decrease in neurodegeneration.
A retrospective cohort study of 28,311 COVID-19 patients in Germany found a significant association between dementia and increased risk of death. The association was weaker than previously reported studies, suggesting potential changes in the impact of dementia on COVID-19 mortality over time.
Researchers at the University of Bonn discovered that people with chronic epilepsy may have impaired dendritic integration, leading to less specific place cell firing and reduced ability to distinguish familiar from unfamiliar places. Administering a sodium ion channel inhibitor improved memory in animal models.
Researchers tested three widely believed aging treatments in mice and found no impact on aging. A new analytical approach allowed them to measure aging processes more precisely, revealing that these treatments promote general health rather than targeting aging mechanisms.
Researchers at UC San Diego have developed a CRISPR-based therapy that targets and destroys mutant RNA molecules causing Huntington's disease. The approach improved motor coordination and reduced toxic protein levels in mouse models, suggesting a potential new treatment direction.
An interdisciplinary team from Erlangen has found a new treatment for Huntington's disease by accelerating the degradation of a specific messenger molecule necessary for protein synthesis. This reduces the huntingtin level in patients, offering new hope for long-term implementation of RNA-modifying approaches for fatal diseases.
A new laboratory test can measure levels of amyloid beta oligomers in blood samples, detecting toxic proteins up to years before cognitive impairment. The test, SOBA, has shown promising results in identifying individuals at risk or incubating Alzheimer's disease.
Scientists have developed an AI method to pinpoint cells indicative of Alzheimer's disease based on DNA packing in mouse brain images, offering a potential early detection tool. This approach combines multi-scale imaging with artificial intelligence to identify biomarkers for aging-related diseases.
Early stage clinical studies confirm 40Hz sensory stimulation is safe, with no serious adverse effects. The therapy also showed significant neurological and behavioral benefits, including improved brain activity, reduced brain atrophy, and better sleep patterns.
The study uses 3D electron microscopy and live cell imaging to observe molecular tethers between organelles. These dynamic structures are constantly binding and unbinding, altering contact site configuration in response to cellular changes.
A survey by UCI MIND found that media coverage of the FDA's decision made people less willing to volunteer for Alzheimer's pharmaceutical trials. The study highlights the powerful influence of media coverage on scientific research and emphasizes the need for diverse populations in clinical trials.
Researchers identified USP7 as a novel cyclin F-interacting protein that stabilizes cyclin F protein. The study also found that USP7 regulates cyclin F mRNA, with pharmacological inhibition resulting in downregulation of cyclin F mRNA.
A new survey by the European Federation of Dietitians supports moderate coffee consumption as having clear health benefits, including improved alertness and sports performance. The study involved 585 dietitians from across 26 European countries.
A new hallmark of ALS has been identified, revealing that loss of the RNA processing protein SFPQ leads to motor neuron degeneration. Defective mRNAs accumulate in axons and interfere with normal function, pointing to a possible new target for therapy.
A new study published in the journal Nature has identified medin as a key player in Alzheimer's therapies. Medin, a protein that accumulates in the blood vessels of the brain, promotes vascular pathology and cognitive decline. The researchers hope to develop a treatment targeting medin to prevent vascular damage and cognitive decline.
The APOE4 gene variant increases the risk of Alzheimer's disease by disrupting the insulation of brain wiring. Research found that oligodendrocytes mismanage cholesterol, failing to transport fat molecules to myelinate axons. This deficiency may contribute to the pathology and symptoms of Alzheimer's.
Researchers at University of Cambridge found that a thin shell of water surrounding proteins can determine aggregation, with slower movement leading to more clumping. The discovery has significant implications for treating protein misfolding diseases like Parkinson's and Alzheimer's.
A Rice University bioengineer has developed a noninvasive technology to measure gene expression in deep tissues, particularly in the brain. This innovation could improve the monitoring of gene therapy treating neurodegenerative disorders such as epilepsy, ALS, and Huntington's disease.
Researchers have identified a new gene, NUCL-1, in the transparent roundworm C. elegans, which is linked to human neurodegenerative diseases such as ALS and Alzheimer's. The discovery challenges recent theories on the role of nuclear structures in these disorders.
A new study found that children with four copies of the SMN2 gene who received pre-symptomatic treatment showed no symptoms, while untreated patients developed irreversible symptoms. The researchers recommend encouraging early intervention in childhood for these patients to avoid potential deficits.
A new study published in Alzheimer's & Dementia found that telmisartan, a blood pressure medication, is associated with lower risk of Alzheimer's specifically in Black patients over 60. The study analyzed data from over 5 million patients and suggests that future clinical trials should prioritize minority populations to find or reinfor...
Researchers from UCLA have developed a strategy to identify novel treatments for cognitive decline and neurodegenerative diseases by exploiting sex differences in the brain. The study provides a roadmap for disentangling the contribution of sex-specific factors, which can yield treatments optimized for each sex.
A study published in the Journal of Alzheimer's Disease found that analyzing patients' drawing tests can help diagnose Alzheimer's disease (AD) and distinguish it from dementia with Lewy bodies (DLB). The researchers discovered that DLB patients showed differences in speed-, pressure-, and pause-related features, whereas AD patients sh...
A study published in Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring found that analyzing patients' speech can distinguish between different types of dementia. The research team developed a machine learning model using speech features to identify Alzheimer's disease and Lewy body dementia.
Researchers have identified a class of lipids called SGDGs that decline in the brain with age and may have anti-inflammatory effects. These findings could lead to new therapeutic interventions for age-related neurological diseases. Further research will be needed to explore the role of SGDGs in human neuroinflammation.
Researchers will investigate immune system differences between men and women to better understand neurodegenerative diseases. The study aims to identify why certain neurological diseases primarily affect males or females, and how this difference impacts disease progression.
Dr. Louise D. McCullough is being recognized for her groundbreaking research on sex differences in stroke and their impact on immune response, which has led to a greater understanding of the biology behind these differences. Her work has also shed light on the importance of including females in pre-clinical research.
A new study by Université Laval researchers has identified a link between insulin receptors in brain microvessels and Alzheimer's disease. The findings suggest that drugs targeting these receptors could be effective in treating the condition, expanding the range of potential treatments.
Scientists at NTU Singapore have found that a stress response in cells, when 'switched on' at a post-reproductive age, could be the key to slowing down aging. The study showed that this stress response extended the lifespan of roundworms fed a high-glucose diet.
A new study aims to diagnose severe neurodegenerative diseases like ALS and FTD with the help of speech tests. AI can analyze subtle nuances of speech patterns, including pauses, speed, and melodic aspects, to detect early changes.
Studies on prion diseases in mice reveal coordinated gene expression changes before symptoms appear, shedding light on selective vulnerability and potential treatment targets. Researchers predict disease progression using new methods, suggesting therapies may be more effective when applied early.
A recent study analyzed the records of over 33,000 dementia patients in Wales and found that those closest to their diagnosis were taking an average of three or more medications. This suggests a possible link between polypharmacy and the development of dementia.
A new CAPSTONE study aims to identify inflammatory biomarkers associated with positive and poor outcomes in patients after intracerebral hemorrhage (ICH) strokes. By analyzing patient blood and plasma samples, researchers hope to develop targeted treatments to prevent long-term brain degeneration.
A systematic review and meta-analysis found that psychotic disorders like schizophrenia are associated with a higher risk of developing dementia. People with psychotic disorders are 2.5 times more likely to develop dementia than those without a psychotic disorder, according to the review.
Scientists have identified long interspersed nuclear element-1 (L1) RNA as a promising new target for treating progeroid syndromes. Increased L1 RNA expression in cells from patients with these disorders led to deactivation of an enzyme, causing cell aging.
Women are more susceptible to Alzheimer's disease due to higher expression of the enzyme ubiquitin-specific peptidase 11 (USP11), which drives increased accumulation of tau protein in brain nerve cells. Researchers hope to develop new neuroprotective medicines based on this finding.
Research reveals Alzheimer's disease genomic changes occur primarily in non-neuronal brain cells, rather than neurons. The study found a number of new genes not previously implicated in dementia, which could be targets for future drug development.
Researchers found mutated PKCγ enzyme leads to elevated activity, disrupting Purkinje cell function and driving cerebellar pathology. The study suggests inhibiting the enzyme may have therapeutic potential for spinocerebellar ataxia type 14 and potentially other subtypes.
The National Institutes of Health has awarded a $10.7 million grant to Cleveland Clinic to expand a national research consortium focused on improving diagnosis and treatments for Dementia with Lewy Bodies. The consortium, which includes multiple clinical sites, aims to identify biomarkers for disease and develop new therapies.
Researchers have discovered that neurons with double-stranded breaks (DSBs) in their DNA actively trigger an inflammatory response, which is mediated by the activation of the NFkappaB transcription factor. This process elicits an immune response from microglia, leading to synaptic loss and cognitive function impairment.
Researchers from Xi'an Jiaotong-Liverpool University found that brain stimulation combined with a nose spray containing nanoparticles can improve recovery after ischemic stroke. The treatment increased cognitive and motor functions, and weighed more quickly than those treated with TMS alone.
A University at Buffalo-led study suggests the huntingtin protein is involved in neuronal injury and regeneration. The research found that HTT moves from the injury site to the cell body, carrying components necessary for survival.
A phase 3 clinical trial showed tofersen reduces SOD1 and neurofilament light protein levels, slowing down disease progression. Longer-term use may help stabilize muscle strength and control in people with genetic ALS.
Research findings suggest that aerobic fitness, cognitive processing speed, and walking endurance are strongly associated in individuals with thalamic atrophy. Aerobic exercise training may be beneficial in restoring function for those with this biomarker of neurodegeneration.
The Critical Path Institute (C-Path) has established a public-private partnership with the FDA and NIH to advance treatments for rare neurodegenerative diseases. The partnership will leverage C-Path's expertise in data management, quantitative analytics, and regulatory science to accelerate medical product development.
A team of researchers has designed in silico molecular probes to track the progress of a misbehaving protein linked to neurodegenerative diseases like ALS and FTD. The probes can detect TDP-43 aggregates at high resolution, paving the way for early diagnosis.
Researchers established a novel strategy to treat Huntington's disease by converting the disease-causing form of the huntingtin protein into its disease-free form. This process maintains the original function of the protein, offering a new approach to tackle the neurodegenerative disorder.